What’s Next for the NIH When it Comes to Psychedelics?
Veriheal
JUNE 24, 2021
The director was spoken to regarding psychedelics and cannabis by Senator Brian Schatz during a Senate Appropriations subcommittee hearing. The Senator stated that the NIH has been reporting on “potentially promising peer-reviewed clinical research” and asked for an update on how the NIH was planning to proceed and navigate issues. .
52 
Let's personalize your content